Understanding Sex Differences in Bladder Cancer
The Kdm6a-dependent Sex Epigenome in Bladder Tumor Suppression
This work explores why bladder cancer affects men more often than women, looking at how sex chromosomes and hormones might play a role.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cedars-Sinai Medical Center NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-11141046 on NIH RePORTER |
What this research studies
We know that bladder cancer is much more common in men than in women, even when accounting for lifestyle factors. This project aims to understand these differences by focusing on a specific gene, KDM6A, which is located on the X chromosome and acts as a tumor suppressor. We believe that differences in this gene's activity, along with sex hormones like androgens and estrogens, create unique biological environments in the bladder for men and women. By understanding these sex-specific factors, we hope to uncover new ways to prevent or treat bladder cancer.
Who could benefit from this research
Good fit: Patients with bladder cancer, particularly those interested in how sex differences influence the disease, may find this research relevant to their condition.
Not a fit: Patients whose bladder cancer is not influenced by the specific genetic or hormonal pathways being studied may not directly benefit from this particular research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to prevent, diagnose, or treat bladder cancer, especially by considering sex-specific biological differences.
How similar studies have performed: While the specific mechanisms of KDM6A and sex hormones in bladder cancer are still being uncovered, other research has shown that sex differences can significantly impact disease development and treatment.
Where this research is happening
Los Angeles, United States
- Cedars-Sinai Medical Center — Los Angeles, United States (Active)
Researchers
- Principal investigator: Li, Xue Sean — Cedars-Sinai Medical Center
- Study coordinator: Li, Xue Sean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.